Ingelvac - Model ATP - Porcine Reproductive and Respiratory Syndrome Vaccine (PRRS) - Brochure

Porcine Reproductive and Respiratory Syndrome (PRRS) is a $664 million dollar problem.⁴ It has a devastating impact on pig performance, overall production and profits. Unlike many other swine diseases, the unique, single-strand RNA structure of the PRRS virus has made it a challenge for generations of pork producers. For the past 20 years, Boehringer Ingelheim Vetmedica Inc. has been helping the industry combat PRRS. With Ingelvac PRRS® vaccines, technical expertise, collaborative research and diagnostic advancements, we are working with veterinarians and producers to win the battles against this challenging disease.